Haemophilus influenzae type B vaccine

Also found in: Dictionary, Thesaurus, Encyclopedia.

Related to Haemophilus influenzae type B vaccine: pneumococcal vaccine

Hae·moph·i·lus in·flu·en·zae type B vac·cine

a conjugate of oligosaccharides of the capsular antigen of H. influenzae type B and diphtheria CRM protein.

Synonym(s): Hib vaccine

Hae·moph·i·lus in·flu·en·zae type B vac·cine

(hē-mof'i-lŭs in-flū-en'zē tīp vak-sēn')

A conjugate of oligosaccharides of the capsular antigen of H. influenzae type B and diphtheria CRM protein.

Haemophilus influenzae type b vaccine

Abbreviation: HIB

A vaccine created by combining purified polysaccharide antigen from the Haemophilus nfluenzae bacteria and a carrier protein. It reduces the risks of childhood epiglottitis, meningitis, and other diseases caused by H. influenzae.

See also: vaccine

References in periodicals archive ?

National vaccination coverage achieved was [greater than or equal to]90% each for three doses of poliovirus vaccine, three doses of Haemophilus influenzae type b vaccine, and one dose of measles-containing vaccine.

National Vaccination Coverage Levels Among Children Aged 19-35 Months -- United States, 1998

The provision of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib) to be used as part of the national childhood immunisation programme, deliveries will be required from 1.4.2017 to 31.3.2019, with an option to extend for up to an additional 24 months.

Contract for the supply of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib)

The provision of diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccine (DTaP/IPV/Hib) to be used as part of the national childhood immunisation programme and deliveries will be required over a period of 1 year with an option to extend for up to an additional 24 months.

Contract for the supply of dtap/ipv/hib

Efficacy of HbOC conjugate Haemophilus influenzae type b vaccine in a study population of 48,000 infants [Abstract].

Food and Drug Administration approval of use of Haemophilus b Conjugate Vaccine for infants